Results 71 to 80 of about 638,455 (170)

Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2011
Primary illness with cytomegalovirus leads to latent infection with possible reactivations especially in the immunocompromised patients. Toxic epidermal necrolysis is an immune mediated cytotoxic reaction.
Dina Khalaf   +3 more
doaj   +1 more source

Interim Update on Reactive Infectious Mucocutaneous Eruption (RIME)

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Reactive infectious mucocutaneous eruption (RIME), a term describing blistering skin and mucosal lesions, is a term coined by a group of Pediatric Dermatology Research Alliance (PeDRA) researchers and first published in 2021. Since that time, the literature has grown with reports of diverse infectious triggers, management strategies, and ...
Michele Ramien   +11 more
wiley   +1 more source

Pathophysiology-Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis [PDF]

open access: yes, 2016
This poster examines recent research into genetic associations and emergent theories concerning the pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal ...
Klein, Douglas M.
core  

Putative cutaneous adverse drug reactions in two dogs

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary We describe two cases of cutaneous adverse drug reactions (CADR) in dogs. Case 1 presented with erythematous macules with sharply demarcated margins on the abdomen and inguinal area and depigmentation on the lip. Skin lesions appeared after 3 weeks of administration of anti‐epileptic drugs, including phenobarbital.
Je‐Seong Kwon   +4 more
wiley   +1 more source

Toxic Epidermal Necrolysis A Diagnostic Dilemma in Puerperium: A Case Report

open access: yesJournal of Nepal Medical Association, 2019
Toxic epidermal necrolysis is a potentially life threatening dermatologic disorder characterized by widespread erythema, necrosis and bullas, detachment of epidermis and mucous membrane resulting in exfoliation, possible sepsis and even death.
Vidya Mahto   +2 more
doaj   +1 more source

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 11, Page 1042-1050, November 2026.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He   +11 more
wiley   +1 more source

Epidermal necrolysis (Stevens–Johnson syndrome and toxic epidermal necrolysis): Historical considerations

open access: yesDermatologica Sinica, 2013
Objective: To describe the history of toxic epidermal necrolysis, before and after the original report by the British dermatologist Alan Lyell in 1956. Methods: Subjective expert choice of key advances in the comprehension of the nosology, classification,
Jean-Claude Roujeau
doaj   +1 more source

Resolution of Paediatric Cow's Milk Allergy Is Associated With Low Tfh Cell Frequencies and Elevated IL‐17 and IL‐22 Levels

open access: yes
Clinical &Experimental Allergy, EarlyView.
Guillaume Lezmi   +7 more
wiley   +1 more source

Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 11, Page 1850-1858, November 2026.
Long‐term sequelae after epidermal necrolysis are frequent, multiple and often severe. Cutaneous, ocular and psychological complications are more frequent, with significant socioeconomic impact. Cluster analysis identifies distinct patient profiles, highlighting the need for personalized multidisciplinary follow‐up.
Thanh Vy Nguyen   +9 more
wiley   +1 more source

TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME)

open access: yesЖурнал инфектологии, 2018
.
E. N. Kudelka   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy